The global hirsutism market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028.
Hirsutism is a condition affecting females that cause excess hair growth on specific body parts, including the face, neck, chest, stomach, lower back, and thighs. It commonly occurs due to excess male hormones, called androgens, and certain medical conditions, such as polycystic ovary syndrome (PCOS). Hirsutism can be treated with medication, topical hair removal products, or through procedures, such as electrolysis, laser therapy, and hair removal equipment. Balding, acne, deepening voice, receding hairline, decreased breast size, and increased muscle mass are some common symptoms of hirsutism.
Hirsutism Market Trends:
The increasing number of hirsutism cases, especially in older women, across the globe is creating a positive outlook for the market. Hirsutism commonly occurs in postmenopausal women by androgen secretion from adrenal or ovarian tumors. Additionally, the rising incidences of bodily disorders due to the presence of excessive body hair in women can cause cosmetic and psychological problems, which, in turn, is favoring the market growth. Moreover, healthcare professionals and activists are sensitizing the masses about available treatments for hirsutism, which is acting as another growth-inducing factor. Apart from this, the increasing demand for hair removal procedures with lasers and intense pulsed light (IPL) equipment requiring multiple treatment sessions is providing an impetus to the market growth. In line with this, manufacturers are focusing on developing topical metformin-based therapeutics that act as an effective treatment for moderate to severe hirsutism in women with PCOS, which is propelling the market growth. Furthermore, the increasing personal care expenditure due to the growing working women population is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, growing acceptance of laser hair removal techniques, and the increasing prevalence of PCOS, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hirsutism market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapy type, products and end user.
Breakup by Therapy Type:
Breakup by Products:
- Hair Removal Equipment
- Topical Hair Removal Products
Breakup by End User:
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alma Lasers Ltd (Sisram Medical Ltd), Alpaya Dermaceuticals, Bayer AG, Cutera Inc., Cynosure Inc., Lumenis Inc., Nisim International Inc. and Sciton Inc.
|Base Year of the Analysis
||Therapy Type, Products, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Alma Lasers Ltd (Sisram Medical Ltd), Alpaya Dermaceuticals, Bayer AG, Cutera Inc., Cynosure Inc., Lumenis Inc., Nisim International Inc. and Sciton Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)